{
  "main_header": {
    "sid": 263659,
    "name": "Kimia Bioscien.",
    "stock_name": "Kimia Bioscien.",
    "full_name": "Kimia Biosciences Ltd",
    "name_url": "stocks-analysis/kimia-bioscien",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.35",
    "chg": 0.55,
    "chgp": "1.73%",
    "dir": 1,
    "prev_price": "31.80",
    "mcapval": "151.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530313,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE285U01025",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.59 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/kimia-bioscien-263659-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 171,
    "sid": "263659",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/kimia-biosciences-263659"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Jun-2026",
      "details": "Publication of Results for quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of The Board Meeting Held On 29 May 2026",
      "datetime": "29-May-2026",
      "details": "Approval of Audited standalone Financial results alongwith Audited Report thereon for financial year 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015",
      "datetime": "20-May-2026",
      "details": "Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone ) for the quarter and financial year ended 31st March 2026 along with the Audit Report thereon",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News